Search Results - "Kozlovskaya, L. I."

Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin by Chernokhaeva, L.L, Rogova, Yu.V, Vorovitch, M.F, Romanova, L.Iu, Kozlovskaya, L.I, Maikova, G.B, Kholodilov, I.S, Karganova, G.G

“…Highlights • Several factors do not affect the assessment of TBE vaccine protective efficacy in vivo. • TBE vaccine Moscow induces immune response in…”
Get full text

Cases of aseptic meningitis after vaccination against mumps in Russia (2009–2019) by Belyaletdinova, I.K., Mitrofanova, I.V., Kozlovskaya, L.I., Ignatyev, G.M.

“…Mumps is a highly contagious viral infection prevented by immunization with live attenuated vaccines. Mumps vaccines have proven to be safe and effective;…”
Get full text

Pre-treatment condition effects on blood pressure and heart rate variability change in patients with arterial hypertension on therapy by Talabanov, P G, Kozlovskaya, I L, Ryabykina, G V, Sobolev, A V, Kozhemyakina, E Sh

“…To study the relationship of the initial clinical and functional state of patients with arterial hypertension (AH) with the dynamics of daily indices of blood…”
Get full text

GAG-binding variants of tick-borne encephalitis virus by Kozlovskaya, L.I, Osolodkin, D.I, Shevtsova, A.S, Romanova, L.Iu, Rogova, Y.V, Dzhivanian, T.I, Lyapustin, V.N, Pivanova, G.P, Gmyl, A.P, Palyulin, V.A, Karganova, G.G

“…Abstract Previously different authors described various flavivirus mutants with high affinity to cell glycosaminoglycans and low neuroinvasiveness in mice that…”
Get full text

Genetic description of a tick-borne encephalitis virus strain Sofjin with the longest history as a vaccine strain by Vorovitch, M. F., Kozlovskaya, L. I., Romanova, L. Iu, Chernokhaeva, L. L., Ishmukhametov, A. A., Karganova, G. G.

“…Vaccines based on the strain Sofjin of the Far-Eastern tick-borne encephalitis virus (TBEV) subtype have been used for TBE prophylaxis for over 50 years in…”
Get full text

Qualitative real-time RT-PCR assay for nOPV2 poliovirus detection by Dolgova, A.S., Kanaeva, O.I., Antonov, S.A., Shabalina, A.V., Klyuchnikova, E.O., Sbarzaglia, V.A., Gladkikh, A.S., Ivanova, O.E., Kozlovskaya, L.I., Dedkov, V.G.

“…Based on the success of the Sabin2-based vaccine, a next-generation nOPV2 poliovirus vaccine has been developed. For epidemic monitoring and conducting…”
Get full text

Heat and cardiovascular diseases: A review of epidemiological surveys by Kozlovskaya, I L, Bulkina, O S, Lopukhova, V V, Chernova, N A, Ivanova, O V, Kolmakova, T E, Karpov, Yu A

“…The review summarizes epidemiologic data on the effects of heat on cardiovascular morbidity and mortality. Patients with heart failure and cardiac arrhythmias…”
Get full text

Synthesis of 5-Halo-2ʹ-Azido Derivatives of Cytidine and N-Hydroxycytidine and Evaluation of Their Antiviral Activity on a Panel of RNA Viruses, Including SARS-CoV-2 by Kamzeeva, P. N., Kolpakova, E. S., Karpova, E. V., Borodulina, M. O., Yakovchuk, E. V., Alferova, V. A., Chistov, A. A., Belyaev, E. S., Kozlovskaya, L. I., Aralov, A. V.

“…Coronavirus disease 2019 (COVID-19) is a new global pandemic with high morbidity and mortality caused by severe acute respiratory syndrome coronavirus 2…”
Get full text

Clinical and epidemiological characteristics of acute flaccid myelitis cases in children registered in the Russian Federation in 2015–2019 by Shakaryan, A. K., Belyaletdinova, I. Kh, Shakhgildyan, S. V., Ivanova, O. E., Eremeeva, T. P., Gmyl, A. P., Baykova, O. Yu, Mustafina, A. N.-I., Kozlovskaya, L. I.

“…Acute flaccid myelitis is a syndrome characterized as the development of acute flaccid paralysis of one or more limbs due to lesions of the anterior horns of…”
Get full text

New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2 by Maslova, A. A., Matyugina, E. C., Shustova, E. Yu, Volok, V. P., Kozlovskaya, L. I., Kochetkov, S. N., Khandazhinskaya, A. L.

“…The development of specific drugs against SARS-CoV-2 infection is a major challenge facing global science and healthcare. Despite numerous attempts, there are…”
Get full text

Development of specific immunity in laboratory animals after co-immunization against seasonal influenza and COVID-19 by Ignatyev, G. M., Leneva, I. A., Atrasheuskaya, A. V., Kozlovskaya, L. I., Kartashova, N. P., Fediakina, I. T., Shustova, E. Yu, Sinyugina, A. A., Zverev, V. V., Trukhin, V. P., Ishmukhametov, A. A.

“…Introduction. In clinical practice, the differential diagnosis of COVID-19 can be challenging during the flu season, entailing serious consequences such as…”
Get full text

Evaluation of the Antiviral Potential of Modified Heterocyclic Base and 5'-Norcarbocyclic Nucleoside Analogs Against SARS-CoV-2 by Matyugina, E S, Novikov, M S, Kozlovskaya, L I, Volok, V P, Shustova, E Y, Ishmukhametov, A A, Kochetkov, S N, Khandazhinskaya, A L

“…The pandemic caused by the novel betacoronavirus SARS-CoV-2 has already claimed more than 3.5 million lives. Despite the development and use of anti-COVID-19…”
Get full text

Peptide Inhibitors of the Interaction of the SARS-CoV-2 Receptor-Binding Domain with the ACE2 Cell Receptor by Bibilashvili, R. Sh, Sidorova, M. V., Dudkina, U. S., Palkeeva, M. E., Molokoedov, A. S., Kozlovskaya, L. I., Egorov, A. M., Ishmukhametov, A. A., Parfyonova, E.V.

“…Computer simulation has been used to identify peptides that mimic the natural target of the SARS-CoV-2 coronavirus spike (S) protein, the…”
Get full text

Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain by Sidorova, M. V., Bibilashvili, R. S., Avdeev, D. V., Kozhokar, U. S., Palkeeva, M. E., Ovchinnikov, M. V., Molokoedov, A. S., Shirokov, D. A., Semyonova, A. V., Uvarova, V. I., Kulyaev, P. O., Khvatov, E. V., Ignatova, A. A., Feofanov, A. V., Osolodkin, D. I., Porozov, Yu. B., Kozlovskaya, L. I., Ishmukhametov, A. A., Parfyonova, Ye. V., Egorov, A. M.

“…The aim of this work was to design and characterize peptides based on the α-helices h1 and h2 of the ACE2 receptor, forming the interaction interface between…”
Get full text

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE? by Karpov, Yu. A., Kozlovskaya, I. L., Bulkina, O. S., Lopukhova, V. V.

“…In the article, a role of percutaneous intervention discussed in stable ischemic disease of the heart, and an evolution presented of the perspectives on its…”
Get full text

A case of vaccine-associated paralytic poliomyelitis in an infant by Shishov, A S, Ivanova, O E, Shakaryan, A K, Kozlovskaya, L I, Mitrophanova, I V, Shachgildyan, S V

“…To present the clinical history, vaccination status, features of the clinical picture, composition of the cerebrospinal fluid (CSF), results of laboratory and…”
Get more information

Measures counteracting 2016 spread of vaccine-derived poliomyelitis virus type 2 in Russian Federation by Popova, A. Yu, Ezhlova, E. B., Melnikova, A. A., Morozova, N. S., Mikhailova, Yu. M., Ivanova, O. E., Kozlovskaya, L. I., Eremeeva, T. P., Gmyl, A. P., Korotkova, E. A., Baykova, O. Yu, Krasota, A. Yu, Ivanenko, А. V., Yarmolskaya, M. S., Kovalchuk, I. V., Romanenko, E. N.

“…Since April 2016 after global cessation of using trivalent oral poliovirus vaccine (tOPV) and switch to bivalent OPV consisting of polioviruses types 1 and 3…”
Get full text

Prevalence of Kemerovo virus in ixodid ticks from the Russian Federation by Dedkov, V G, Markelov, M L, Gridneva, K A, Bekova, M V, Gmyl, A P, Kozlovskaya, L I, Karganova, G G, Romanova, L Iu, Pogodina, V V, Yakimenko, V V, Shipulin, G A

“…The prevalence of Kemerovo virus in ixodid ticks collected in 2008-2012 from 11 regions of the Russian Federation was investigated by real-time…”
Get full text

New Analogues of Uridine as Possible Anti-Viral Agents Specific to SARS-CoV-2 by Maslova, A A, Matyugina, E C, Shustova, E Yu, Volok, V P, Kozlovskaya, L I, Kochetkov, S N, Khandazhinskaya, A L

“…The development of specific drugs against SARS-CoV-2 infection is a major challenge facing global science and healthcare. Despite numerous attempts, there are…”
Get more information

Neutralizing Antibody Spectrum in COVID-19 Patients who Became Ill During the Circulation of Different SARS-CoV-2 Variants by Pylaeva, S. K., Kozlovskaya, L. I., Erovichenkov, A. A., Sirazova, D. I., Shustova, E. Y., Artamonova, E. A., Sinyugina, A. A., Gordeychuk, I. V., Troshyanskiy, D. V., Kosareva, E. V., Solodovnikova, O. N., Kogotyzhev, R. K., Berestovskaia, A. U., Tyurin, I. N., Protsenko, D. N., Ishmukhametov, A. A.

“…SARS-CoV-2 has been actively circulating in the human population since late 2019. During this time, the virus acquired more than 140 nucleotide mutations and…”
Get full text